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Introduction
Ten to fifteen percent of all diagnosed cerebral tumours are
pituitary adenomas (60%–70% are secreting adenomas) that
frequently occur during the 3rd or 4th decades of life. Half
of them are diagnosed early by clinical hormonal symptoms
even when the dimensions of the adenomas are small (5
mm) and the tumours are undetected on magnetic resonance
imaging (MRI) scans. Among these, however, growth hor-
mone (GH)-producing macroadenomas are uncommon, and
often have blood hormonal levels so low that their diagnosis
could be delayed [1, 2]. In 10% of the adult population, MRI
scans can detect silent pituitary adenomas [3].
Thirty-three to seventy-two percent of pituitary adeno-
mas, independently of their dimensions, induce headache
[4, 5]. Headache is the first symptom in about 11% of
women and in about 15% of men [6]. Some studies have
suggested that the incidence of headache was 57.1% in
non-functioning adenomas [7] and 60% in GH-secreting
adenomas [8]. Headache seems to be more frequent in
prolactin (PRL)-secreting adenomas (57.1%) than in GH-
secreting adenomas (12.5%) [9]. Headache, more fre-
quently localised to the frontal region, is bilateral (89.5%)
or monolateral (84.2%) and sometimes diffuse (42.1%).
Pain is continuous or pressing-heavy, and rarely pulsat-
ing-intermittent (mostly in female patients) (57.9%) [9].
Headaches due to GH-secreting adenomas, with or
without acromegaly, do not have significant sellar abnor-
malities or visual problems [5, 8].
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Abstract A 66-year-old man suf-
fered from a drug-resistant, left-
sided headache with autonomic
signs, triggered by the supine
position. The acromegalic facies
initially suggested a possible
increase in basal plasma levels of
GH, but routine haematological
controls excluded abnormal values
of GH. Cerebral and facial CT
scan and MRI did not detect any
alterations in the nasal sinuses,
except for a mucous cyst. Surgical
ablation of the cyst did not allevi-
ate the pain. Further endocrinolog-
ical tests demonstrated an increase
of IGF-1 (somatomedin C), and
another MRI scan of the sellar
region confirmed the presence of a
pituitary macroadenoma on the
left paramedian side. After an ini-
tial improvement of the sympto-
matology due to trans-sphenoidal
ablation of a benign GH-producing
macroadenoma, the headache
worsened again. Pain was well
correlated with the increased plas-
ma levels of IGF-1. The patient
died suddenly for myocardial
infarct.
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Case history
A 56-year-old patient, without familiarity of headache,
suffered from headache for the last 20 years of his life.
He was referred to our headache centre where he was
treated for 10 years until he died. From the beginning, the
almost daily headache had a pressing quality, was
localised on the left temporal side, and lasted 7–8 h. Pain
was usually diffuse to the ipsilateral orbito-frontal and/or
maxillary regions, associated with bilateral blurred
vision, lacrimation, conjunctival injection and rhinor-
rhoea (only on the left side), but not with nausea or vom-
iting. Physical activity did not modify the pain. The
headache usually started during the evening. The sleeping
position exacerbated the associated autonomic symp-
toms; instead, the orthostatic position and/or walking
alleviated the pain. In fact, the patient frequently stood up
during the night.
Over time, the headache worsened in intensity and
frequency: attacks became continuous and intolerable,
without relief during the day or after pharmacological
treatment.
In 1992, the patient was referred to our headache cen-
tre with a diagnosis (formulated in 1988) of “antero-sep-
tal coronary infarct, double coronary artery by-pass
surgery, diabetes mellitus, and unspecified paroxysmal
headache”. During the initial diagnostic work-up at our
headache centre, the patient underwent an otological visit
that evidenced hypertrophy of the inferior turbinates and
right deviation of the nasal septum. This alteration sug-
gested the diagnosis of “Headache associated with a dis-
order of nose and sinuses” according to the International
Classification of Headache Disorders (ICHD)-II [10].
Five years later, a follow-up visit revealed the pres-
ence of acromegalic facies; however, plasma GH levels
were normal. In the same year, the patient underwent a
computed tomography (CT) scan of the nasal sinuses that
showed the presence of a mucous cyst (2.5 cm in diame-
ter) in the alveolar recess of the left maxillary sinus. The
cyst was surgically removed one month after the instru-
mental diagnosis, but with no modification of the
headache.
A cluster-like headache (CLH) was suspected for the
possible involvement of trigeminal fibres stimulated by
abnormalities of the nasal sinus, as suggested by the
otological visit. The cardiovascular parameters of the
patient, strictly monitored by the cardiologist, were
normal, thus allowing administration of sumatriptan
and oxygen, with only slight improvement of the pain.
Also, verapamil (360 mg/day) and prednisone (50
mg/day) prophylaxis, as well as instillation of Bonheim
solution (cocaine 1/3, phenol 1/3 and menthol 1/3) on
the sphenopalatine ganglion were ineffective.
In October 2000, an MRI scan of the brain and
paranasal sinuses showed a small, 5–7 mm diameter focal
area in the right cerebellar hemisphere that was identified
as a capillary telangiectasia. A subsequent cerebral MRI
scan (February 2001) revealed a small ischaemic lesion
of the right frontal region, probably related to severe
stenosis of the right internal carotid artery. The patient
subsequently underwent carotid endarterectomy.
Headache persisted for six months and a routine con-
trol of haematological parameters revealed an increase in
the erythrocyte sedimentation rate (ESR) of 44 mm (nor-
mal: 2–15 mm), and C-reactive protein (CRP) of 240
mg/dl (normal: <80). The high values of ESR and CRP,
the patient’s age, and the spontaneous and/or evoked
pain on the left temporal side suggested a probable
Horton’s arteritis. This hypothesis was not confirmed by
histological examination, which showed chronic inflam-
mation of the external layer without typical multi-
nuclear giant cells.
In May 2001, a new endocrinologic screening test
revealed an increase in IGF-1 (somatomedin C) (665
ng/ml; normal range: 44–279 ng/ml). Two months later,
the patient underwent a specific MRI scan of the sellar
region, which revealed a pituitary macroadenoma (12
mm diameter) on the left paramedian side. This lesion
reached the left side of the cavernous sinus without infil-
tration of the sinus wall. The optic chiasm was not
involved. In October 2001, the pituitary macroadenoma
was removed by trans-sphenoidal procedure. The histo-
logical examination revealed a benign GH-secreting
macroadenoma.
Three months after surgery, the headache signifi-
cantly improved without any prophylactic therapy; the
pain disappeared during the day and was greatly
reduced during the night. Only a mild, left frontal-tem-
poral pressing headache persisted and nocturnal rest
improved. Other clinical features persisted: evoked pain
in the left temporal region, moderate increase of arteri-
al blood pressure (150/90 mmHg) and ventricular con-
centric hypertrophy.
In February 2002, a further cerebral and facial MRI
with contrast enhancement revealed a hypodense area of
the left paramedian side of the sella turcica. This area was
considered a result of previous surgery or a residual of the
tumour. The contemporary IGF-1 levels showed a 35%
reduction compared to previous levels (402.2 ng/ml).
Although neuroradiological examination failed to confirm
involvement of the optic chiasm, visual field testing
revealed the presence of a partial, bitemporal hemianop-
sia, more evident on the left side.
One month later, in March 2002, during a subsequent
medical control, the patient referred a new, mild worsen-
ing of the headache. Nocturnal hyposensitivity and
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paraesthesia of the arms, previously alleviated during
movement, worsened again. The persisting high levels of
IGF-1 (444.4 ng/ml), acromegalic-like symptoms and the
last neuroradiological report suggested the hypothesis of
a residual GH-secreting adenoma located behind the left
carotid sinus.
The patient was re-evaluated by the neurosurgeon and
endocrinologist, and both specialists decided to begin
inhibitor therapy with octreotide before attempting anoth-
er surgical approach. In June 2002, in spite of specific
therapy, the levels of IGF-1 increased to 473.5 ng/ml,
without any improvement in the symptomatology. In July
2002, the patient died suddenly, probably from relapse of
a myocardial infarction. An autopsy was not performed
for legal reasons.
Discussion
GH-producing macroadenomas are uncommon secreting
adenomas, often with a delayed diagnosis, especially due
to poor laboratory diagnostic support [6].
Several authors report CLH related to facial and cav-
ernous sinus diseases [11]. The mechanisms underlying
these symptoms are the object of discussion. Hannerz [12]
hypothesised that the adenoma induced an impairment of
venous flow in the carotid sinus and/or of the superior
ophthalmic vein with subsequent vasculitis of the orbital
sinus. These events caused stimulation of the first or sec-
ond trigeminal branches and activation of the trigemino-
vascular system [12–15]. Other authors hypothesised,
instead, that the adenoma pulled on the bony sellar septum
and excited the meningeal arteries and trigeminal fibres
located there [4, 16].
In the case of CLH, inflammation of the sphenoidal
sinus due to aspergilloma was reported by Zanchin [15],
while inflammation of other nasal sinuses was suggested
by Takeshima [17] and Molins [18]. CLH was referred to
be secondary to the subclavian steal phenomenon [19],
and recently a case of migraine with aura was reported
that resolved after treatment of a PRL-secreting pituitary
microadenoma [20].
In our case, a differential diagnosis between maxillary
sinus infection and sphenoidal sinusitis was made. Also
considered was the diagnosis of Horton’s arteritis
because of the age of the patient, the increase in ESR and
CRP, and the site and pattern of pain. The patient’s
headache did not fulfil ICHD-II criteria for CLH; in fact,
crises so prolonged and pain so progressive and exacer-
bated by the supine position are suggestive of a sec-
ondary form of headache. Another possible diagnosis was
tension-type headache.
CT scans in patients affected by acromegaly or sinusi-
tis show a major prevalence of significant morphological
differences in the bone and soft tissue of the nasal cavity
that cause a deeper and narrower surgical field [21]. The
hyper-secretion of GH increased the volume of the
turbinate bones and induced an alteration of efflux from
the nasal cavity.
In our case, thickening of the bone, hypertrophy of
the nasal sinus mucosa and compression of the left
cavernous sinus correlated with GH-secreting adenoma
caused the acromegalic aspect. GH-secreting adenoma
and acromegaly could both be responsible for the entire
observed symptomatology, including headache. In fact,
symptoms of a possible acromegaly had been observed
since 1997, but normal blood levels of GH delayed
further endocrinologic and neuroradiologic investiga-
tions. Early testing for IGF-1, whose half-life is longer
than that of GH, could probably lead to a positive
finding not unbiased by the intermittent secretion of
GH [22].
During the first clinical phase, headache relapse could
possibly be correlated to the increase of IGF-1 rather
than to structural abnormalities of the sella turcica.
Surgical ablation of the mucous cyst in the maxillary
sinus worsened the headache, probably due to a local,
non-specific inflammatory reaction. Octreotide adminis-
tration in the last clinical stage was reported to induce
analgesic effects [23].
The peptide, octreotide, induced analgesia with a
mechanism that is independent of the inhibition of GH
production. Octreotide, in fact, interfered in the synthesis
of peptides, such as substance P, by the tumour or by the
trigeminal nucleus [24, 25].
In conclusion, the diagnosis of pituitary adenoma
remains difficult and is frequently delayed. Using MRI,
silent pituitary adenomas are found in 10% of a random
adult population [3], while occult adenomas are
described in a large range (3%–27%) of post mortem
examinations [26].
It is reasonable to hypothesise a GH-producing pitu-
itary adenoma associated with monolateral headache and
autonomic signs, mostly involving a direct stimulation of
the trigeminovascular system [11]. An additional effect
could be linked to the bone and mucosal modifications
induced by GH and related hormones in the sinus areas. A
large number of observations suggest that the pain and
autonomic symptoms, which originated within the cav-
ernous sinus, derived from tumour impairment of the
venous drainage [12].
Finally, we emphasise that clinical examination, as
well as neuroimaging, remains essential for properly eval-
uating patients referring with clinical pictures not fulfill-
ing ICHD-II criteria.
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